Glial contributions to neurodegeneration in tauopathies

by Cheryl E. G. Leyns, David M. Holtzman
Published 2017-06-01

New insights into the role of TREM2 in Alzheimer’s disease

by Maud Gratuze, Cheryl E. G. Leyns, David M. Holtzman
Published 2018-12-01

Targeting tauopathy with engineered tau-degrading intrabodies

by Gilbert Gallardo, Connie H. Wong, Sara M. Ricardez, Carolyn N. Mann, Kent H. Lin, Cheryl E. G. Leyns, Hong Jiang, David M. Holtzman
Published 2019-10-01

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease

by Hardy J. Rideout, Marie-Christine Chartier-Harlin, Marie-Christine Chartier-Harlin, Matthew J. Fell, Warren D. Hirst, Sarah Huntwork-Rodriguez, Cheryl E. G. Leyns, Omar S. Mabrouk, Jean-Marc Taymans, Jean-Marc Taymans
Published 2020-08-01